| Year |
Citation |
Score |
| 2023 |
Vieira M, Andia T, Karim O, Srishti SA, Pineda SA, Alonso Ruiz A, Large K, Liu Y, Moon S, Naher N, Siddiqui A, Ahmed SM. Rising pharmaceutical innovation in the Global South: a landscape study. Journal of Pharmaceutical Policy and Practice. 16: 155. PMID 38012700 DOI: 10.1186/s40545-023-00669-3 |
0.318 |
|
| 2022 |
Borghi J, Ismail S, Hollway J, Kim RE, Sturmberg J, Brown G, Mechler R, Volmink H, Spicer N, Chalabi Z, Cassidy R, Johnson J, Foss A, Koduah A, Searle C, ... ... Moon S, et al. Viewing the global health system as a complex adaptive system - implications for research and practice. F1000research. 11: 1147. PMID 37600221 DOI: 10.12688/f1000research.126201.1 |
0.36 |
|
| 2021 |
Moon S, Armstrong J, Hutler B, Upshur R, Katz R, Atuire C, Bhan A, Emanuel E, Faden R, Ghimire P, Greco D, Ho CW, Kochhar S, Schaefer GO, Shamsi-Gooshki E, et al. Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability. Lancet (London, England). 399: 487-494. PMID 34902308 DOI: 10.1016/S0140-6736(21)02344-8 |
0.315 |
|
| 2020 |
Suleman F, Low M, Moon S, Morgan SG. New business models for research and development with affordability requirements are needed to achieve fair pricing of medicines. Bmj (Clinical Research Ed.). 368: l4408. PMID 31932324 DOI: 10.1136/Bmj.L4408 |
0.364 |
|
| 2020 |
Morgan SG, Bathula HS, Moon S. Pricing of pharmaceuticals is becoming a major challenge for health systems. Bmj (Clinical Research Ed.). 368: l4627. PMID 31932289 DOI: 10.1136/Bmj.L4627 |
0.379 |
|
| 2019 |
Moon S. Power in global governance: an expanded typology from global health. Globalization and Health. 15: 74. PMID 31775779 DOI: 10.1186/S12992-019-0515-5 |
0.427 |
|
| 2019 |
Reid MJA, Arinaminpathy N, Bloom A, Bloom BR, Boehme C, Chaisson R, Chin DP, Churchyard G, Cox H, Ditiu L, Dybul M, Farrar J, Fauci AS, Fekadu E, Fujiwara PI, ... ... Moon S, et al. Building a tuberculosis-free world: The Lancet Commission on tuberculosis. Lancet (London, England). PMID 30904263 DOI: 10.1016/S0140-6736(19)30024-8 |
0.387 |
|
| 2018 |
Leigh J, Fitzgerald G, Garcia E, Moon S. Global epidemics: how well can we cope? Bmj (Clinical Research Ed.). 362: k3254. PMID 30101744 DOI: 10.1136/Bmj.K3254 |
0.33 |
|
| 2017 |
Chaumont C, Hsi J, Bohne C, Mostaghim S, Moon S. A New Golden Age? Proposal for an Innovative Global Health Funding Mechanism for Middle-Income Countries. Global Challenges (Hoboken, Nj). 1: 1700015. PMID 31565286 DOI: 10.1002/gch2.201700015 |
0.344 |
|
| 2017 |
Moon S, Ooms G. Will markets be master or servant to health at the World Bank? Bmj (Clinical Research Ed.). 359: j4676. PMID 29042353 DOI: 10.1136/Bmj.J4676 |
0.401 |
|
| 2017 |
Ottersen T, Elovainio R, Evans DB, McCoy D, Mcintyre D, Meheus F, Moon S, Ooms G, Røttingen JA. Towards a coherent global framework for health financing: recommendations and recent developments. Health Economics, Policy, and Law. 12: 285-296. PMID 28332466 DOI: 10.1017/S1744133116000505 |
0.485 |
|
| 2017 |
Ottersen T, Moon S, Røttingen JA. The challenge of middle-income countries to development assistance for health: recipients, funders, both or neither? Health Economics, Policy, and Law. 12: 265-284. PMID 28332465 DOI: 10.1017/S1744133116000499 |
0.484 |
|
| 2017 |
Ottersen T, Moon S, Røttingen JA. Distributing development assistance for health: simulating the implications of 11 criteria. Health Economics, Policy, and Law. 12: 245-263. PMID 28332464 DOI: 10.1017/S1744133116000487 |
0.413 |
|
| 2017 |
Moon S, Omole O. Development assistance for health: critiques, proposals and prospects for change. Health Economics, Policy, and Law. 12: 207-221. PMID 28332463 DOI: 10.1017/S1744133116000463 |
0.462 |
|
| 2017 |
Ottersen T, Kamath A, Moon S, Martinsen L, Røttingen JA. Development assistance for health: what criteria do multi- and bilateral funders use? Health Economics, Policy, and Law. 12: 223-244. PMID 28332462 DOI: 10.1017/S1744133116000475 |
0.439 |
|
| 2017 |
Moon S, Røttingen JA, Frenk J. Global public goods for health: weaknesses and opportunities in the global health system. Health Economics, Policy, and Law. 12: 195-205. PMID 28332461 DOI: 10.1017/S1744133116000451 |
0.515 |
|
| 2017 |
Moon S, Leigh J, Woskie L, Checchi F, Dzau V, Fallah M, Fitzgerald G, Garrett L, Gostin L, Heymann DL, Katz R, Kickbusch I, Morrison JS, Piot P, Sands P, et al. Post-Ebola reforms: ample analysis, inadequate action. Bmj (Clinical Research Ed.). 356: j280. PMID 28115316 DOI: 10.1136/Bmj.J280 |
0.443 |
|
| 2017 |
Moon S. Powerful Ideas for Global Access to Medicines. The New England Journal of Medicine. PMID 28099819 DOI: 10.1056/Nejmp1613861 |
0.442 |
|
| 2016 |
Anadon LD, Chan G, Harley AG, Matus K, Moon S, Murthy SL, Clark WC. Making technological innovation work for sustainable development. Proceedings of the National Academy of Sciences of the United States of America. PMID 27519800 DOI: 10.1073/Pnas.1525004113 |
0.584 |
|
| 2016 |
Gostin LO, Tomori O, Wibulpolprasert S, Jha AK, Frenk J, Moon S, Phumaphi J, Piot P, Stocking B, Dzau VJ, Leung GM. Toward a Common Secure Future: Four Global Commissions in the Wake of Ebola. Plos Medicine. 13: e1002042. PMID 27195954 DOI: 10.1371/Journal.Pmed.1002042 |
0.406 |
|
| 2016 |
Sridhar D, Kickbusch I, Moon S, Dzau V, Heymann D, Jha AK, Saavendra J, Stocking B, Woskie L, Piot P. Facing forward after Ebola: questions for the next director general of the World Health Organization. Bmj (Clinical Research Ed.). 353: i2666. PMID 27193334 DOI: 10.1136/Bmj.I2666 |
0.46 |
|
| 2015 |
Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, Edwin V, Fallah M, Fidler DP, Garrett L, Goosby E, Gostin LO, Heymann DL, Lee K, Leung GM, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet (London, England). PMID 26615326 DOI: 10.1016/S0140-6736(15)00946-0 |
0.391 |
|
| 2014 |
Sridhar D, Frenk J, Gostin L, Moon S. Global rules for global health: why we need an independent, impartial WHO. Bmj (Clinical Research Ed.). 348: g3841. PMID 24942299 DOI: 10.1136/Bmj.G3841 |
0.469 |
|
| 2014 |
Ottersen OP, Dasgupta J, Blouin C, Buss P, Chongsuvivatwong V, Frenk J, Fukuda-Parr S, Gawanas BP, Giacaman R, Gyapong J, Leaning J, Marmot M, McNeill D, Mongella GI, Moyo N, ... ... Moon S, et al. The political origins of health inequity: prospects for change. Lancet. 383: 630-67. PMID 24524782 DOI: 10.1016/S0140-6736(13)62407-1 |
0.384 |
|
| 2014 |
Moon S. WHO's role in the global health system: what can be learned from global R&D debates? Public Health. 128: 167-72. PMID 24393496 DOI: 10.1016/J.Puhe.2013.08.014 |
0.446 |
|
| 2014 |
Frenk J, Gómez-Dantés O, Moon S. From sovereignty to solidarity: a renewed concept of global health for an era of complex interdependence. Lancet (London, England). 383: 94-7. PMID 24388312 DOI: 10.1016/S0140-6736(13)62561-1 |
0.496 |
|
| 2013 |
Frenk J, Moon S. Governance challenges in global health. The New England Journal of Medicine. 368: 936-42. PMID 23465103 DOI: 10.1056/Nejmra1109339 |
0.455 |
|
| 2012 |
Moon S, Bermudez J, 't Hoen E. Innovation and access to medicines for neglected populations: could a treaty address a broken pharmaceutical R&D system? Plos Medicine. 9: e1001218. PMID 22615544 DOI: 10.1371/Journal.Pmed.1001218 |
0.438 |
|
| 2011 |
Moon S, Jambert E, Childs M, von Schoen-Angerer T. A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries. Globalization and Health. 7: 39. PMID 21992405 DOI: 10.1186/1744-8603-7-39 |
0.348 |
|
| 2011 |
Hoen E', Berger J, Calmy A, Moon S. Driving a decade of change: HIV/AIDS, patents and access to medicines for all. Journal of the International Aids Society. 14: 15. PMID 21439089 DOI: 10.1186/1758-2652-14-15 |
0.341 |
|
| 2010 |
Waning B, Diedrichsen E, Jambert E, Bärnighausen T, Li Y, Pouw M, Moon S. The global pediatric antiretroviral market: analyses of product availability and utilization reveal challenges for development of pediatric formulations and HIV/AIDS treatment in children. Bmc Pediatrics. 10: 74. PMID 20950492 DOI: 10.1186/1471-2431-10-74 |
0.387 |
|
| 2010 |
Waning B, Diedrichsen E, Moon S. A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries. Journal of the International Aids Society. 13: 35. PMID 20840741 DOI: 10.1186/1758-2652-13-35 |
0.398 |
|
| 2010 |
Waning B, Kyle M, Diedrichsen E, Soucy L, Hochstadt J, Bärnighausen T, Moon S. Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Globalization and Health. 6: 9. PMID 20500827 DOI: 10.1186/1744-8603-6-9 |
0.401 |
|
| 2010 |
Moon S, Szlezák NA, Michaud CM, Jamison DT, Keusch GT, Clark WC, Bloom BR. The global health system: lessons for a stronger institutional framework. Plos Medicine. 7: e1000193. PMID 20126249 DOI: 10.1371/Journal.Pmed.1000193 |
0.48 |
|
| 2010 |
Keusch GT, Kilama WL, Moon S, Szlezák NA, Michaud CM. The global health system: linking knowledge with action--learning from malaria. Plos Medicine. 7: e1000179. PMID 20087415 DOI: 10.1371/Journal.Pmed.1000179 |
0.481 |
|
| 2010 |
Szlezák NA, Bloom BR, Jamison DT, Keusch GT, Michaud CM, Moon S, Clark WC. The global health system: actors, norms, and expectations in transition. Plos Medicine. 7: e1000183. PMID 20052277 DOI: 10.1371/Journal.Pmed.1000183 |
0.419 |
|
| Show low-probability matches. |